Swedish trading company Bufab Group completed the acquisition of Novia Group – a German-based provider of global sourcing solutions and engineering services operating across Germany, Switzerland, China, and Vietnam – from the German investment company Family Trust. In connection with the deal, Pestalozzi advised Bufab Group, Vischer represented Family Trust, while Reed Smith acted as […]
Niederer Kraft Frey (NKF) advised SoftBank Group Corp in its agreement with electrification and automation specialist ABB to acquire the latter’s robotics business, valued at USD 5.375 billion. Closing is planned for mid-to-late 2026, subject to
Niederer Kraft Frey (NKF) advised Impala Terminals Group (Impala), a globally active liquid and dry bulk storage infrastructure operator, in connection with its recent USD 1.26 billion debt refinancing and private placement notes issuance. A&
Walder Wyss advised GlobalLogic, a US subsidiary of the Japanese Hitachi Group, and its lead legal advisor, the German law firm, on the acquisition of the Synvert Group from private equity fund Maxburg. The parties
MME, in collaboration with the German law firm Wendelstein, advised Blackroll on its acquisition of Berlin-based startup Eaze, a specialist in digital sleep coaching. The legal teams The MME lineup on the matter included partner
Niederer Kraft Frey (NKF) is advising Georg Fischer (GF), as the Swiss industrial company listed at SIX Swiss Exchange stipulated an agreement to divest its iron foundry operation to Linamar Corp, a globally active manufacturer
Kellerhals Carrard advised the Stef Group, a listed company active in logistics and transport of food products with headquarters in France, on the acquisition of Swiss food transport company Christian Cavegn by the Group’s
Wenger Vieli advised the shareholders of Tripleblue, a provider of AI solutions with a focus on HOA management, in connection with its sale to property-tech specialist Aareon. The Wenger Vieli team Partner Michael Baier (corporate/
Walder Wyss advised Fielmann Group and tele-ophthalmology platform Ocumeda, as the the first agreed to sell a 10% stake in Ocumenda to Zeiss Vision Care. The deal implied a total company valuation of EUR 100m, with
Lenz & Staehelin advised private equity healthcare specialist Archimed on its acquisition of a majority stake in family-owned ExcellGene and sister company Magellan Biologics & Consulting, both active in the biologic therapeutics sector. The deal
